Bulletin
Investor Alert

New York Markets Close in:

Sept. 14, 2019, 12:46 a.m. EDT

CAR-T Cell Therapy Market: Global Industry Analysis and Opportunity Assessment 2019-2025

Sep 14, 2019 (Brandessence Market Research via COMTEX) -- The CAR-T Cell Therapy Market research report delivers a comprehensive analysis on the newest market drivers. The report also offers extracts regarding statistics, market valuation and revenue estimates, which further strengthens its status in the competitive spectrum and growth trends embraced by leading manufacturers in the business.

Scope of The Report:

Report evaluates the growth rate and the Market value based on Market dynamics, growth inducing factors. The complete knowledge is based on latest industry news, opportunities and trends. The report contains a comprehensive Market analysis and vendor landscape in addition to a SWOT analysis of the key vendors.

Key Benefits for CAR-T Cell Therapy Market Reports

Global market report covers in-depth historical and forecast analysis.

Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.

Global market report helps to identify opportunities in market place.

Global market report covers extensive analysis of emerging trends and competitive landscape.

Get Sample Copy of This Premium Report @ https://industrystatsreport.com/Request/Sample?ResearchPostId=783&RequestType=Sample

The CAR-T Cell Therapy Market Report provides key strategies followed by leading CAR-T Cell Therapy industry manufactures and Sections of Market like- product specifications, volume, production value, Feasibility Analysis, Classification based on types and end user application areas with geographic growth and upcoming advancement. The CAR-T Cell Therapy market report provides comprehensive outline of Invention, Industry Requirement, technology and production analysis considering major factors such as Revenue, investments and business growth.

The detailed market intelligence report on the Global CAR-T Cell Therapy Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global CAR-T Cell Therapy Market place for the forecast 2019- 2025.

This report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global CAR-T Cell Therapy Market.

CAR-T Cell Therapy Market Segmentation:
By Target Antigen
CD19
CD22
Others

By Application
Acute Lymphoblastic Leukemia
Diffuse Large B-Cell Lymphoma
Others

By Region
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Russia
Rest of Europe
Asia-Pacific
China
South Korea
India
Japan
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa

CAR-T Cell Therapy Market Key Players:
AbbVie Inc.
Adaptimmune Therapeutics PLC
Amgen, Inc.
Atara Biotherapeutics, Inc.
Aurora Biopharma, Inc.
Autolus Therapeutics PLC
Bellicum Pharmaceuticals, Inc.
BioAtla LLC
bluebird bio
Carina Biotech
Others

The foremost points are labelled in detail which are covered in this CAR-T Cell Therapy Market Report: -

Market Overview: Scope & Product Overview, Classification of CAR-T Cell Therapy by Product Category (Market Size (Sales), Market Share Comparison by Type (Product Category)), CAR-T Cell Therapy Market by Application/End Users (Sales (Volume) and Market Share Comparison by Application), Market by Region (Market Size (Value) Comparison by Region, Status and Prospect

CAR-T Cell Therapy Market by Manufacturing Cost Analysis: Key Raw Materials Analysis, Price Trend of Key Raw Materials, Key Suppliers of Raw Materials, Market Concentration Rate of Raw Materials, Proportion of Manufacturing Cost Structure (Raw Materials, Labor Cost), Manufacturing Process Analysis

CAR-T Cell Therapy Players/Suppliers Profiles and Sales Data: Company, Company Basic Information, Manufacturing Base and Competitors, Product Category, Application and Specification with Sales, Revenue, Price and Gross Margin, Main Business/Business Overview.

Request for Methodology @ https://industrystatsreport.com/Request/Sample?ResearchPostId=783&RequestType=Methodology

Table of Content
1. Chapter - Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP's of Report
1.8. Report Description
2. Chapter - Global CAR-T Cell Therapy Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global CAR-T Cell Therapy Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. CAR-T Cell Therapy Market: Trends
2.8. Porter's Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis
2.9.1. Market Attractiveness Analysis by Segmentation
2.9.2. Market Attractiveness Analysis by Region
............
8. Chapter - Company Profiles
8.1. AbbVie Inc.
8.1.1. Overview
8.1.2. Financials
8.1.3. Product portfolio
8.1.4. CAR-T Cell Therapy Market Revenue (USD Million) and Market Share (%), 2014 - 2018
8.1.5. CAR-T Cell Therapy Sales Market Share (%), 2014 - 2018
8.1.6. Business strategy
8.1.7. Recent developments
8.2. Adaptimmune Therapeutics PLC
8.3. Amgen, Inc.
8.4. Atara Biotherapeutics, Inc.
8.5. Aurora Biopharma, Inc.
8.6. Autolus Therapeutics PLC
8.7. Bellicum Pharmaceuticals, Inc.
8.8. BioAtla LLC
8.9. bluebird bio
8.10. Carina Biotech
8.11. CARsgen Therapeutics, Ltd.
8.12. CARTherics
8.13. Celgene
8.14. Cellectis
8.15. Celularity
8.16. Celyad SA
8.17. Creative Biolabs
8.18. DiaCarta, Inc.
8.19. Endocyte, Inc.
8.20. F1 Oncology, Inc.
8.21. Fate Therapeutics Inc.
8.22. Gilead
8.23. Humanigen, Inc.
8.24. Immune Therapeutics, Inc.
8.25. Intrexon, Corp.
8.26. Juno Therapeutics, Inc.
8.27. Kite Pharma, Inc.
8.28. Lion TCR Pte Ltd.
8.29. MaxCyte, Inc.
8.30. Mesoblast, Ltd.
8.31. Minerva Biotechnologies Corp.
8.32. Mustang Bio, Inc.
8.33. Novartis AG
8.34. Oxford BioMedica PLC.
8.35. PeproMene Bio Inc.
8.36. Pfizer, Inc.
8.37. Posedia Therapeutics Inc.
8.38. Precision Biosciences, Inc.
8.39. ProMab Biotechnologies Inc.
8.40. Servier Oncology
8.41. Sorrento Therapeutics, Inc.
8.42. TC Biopharm Ltd.
8.43. Tessa Therapeutics Pte Ltd.
8.44. TILT Biotherapeutics Ltd.
8.45. Tmunity Therapeutics Inc.
8.46. TrakCel Ltd.
8.47. Xyphos
8.48. ZIOPHARM Oncology, Inc.
8.49. Others

Continued..............

Buy this Report @ https://industrystatsreport.com/Buy/Create?ResearchPostId=783&RequestType=Buy&PurchasePlan=SingleUser

About Us:

We publish market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students.

Contact US:

Contact us at: +44-2038074155 or mail us at sales@brandessenceresearch.com

Website: https://brandessenceresearch.biz

Blogs: http://www.brandessencejournal.com

Blogs : http://www.technologystatsnews.com

Blogs: https://dailynewscollectors.com

COMTEX_352261684/2625/2019-09-14T00:45:57

Link to MarketWatch's Slice.